★★★

B2En

B2En Faces Severe Dilution and Governance Risk from Heavily Discounted Capital Increase and Change of Control


  • B2En's largest shareholder changed from Extwins1 Fund to Strage1 Fund, with a third-party allotment capital increase of 14.73 million shares issued at approximately 54% discount, diluting existing shareholders by 19.8%.
  • The 12.52 million shares transferred are not subject to any lock-up, and the new shares were issued well below market price, raising concerns about short-term profit-taking and additional downward pressure on the stock.
  • The new major shareholder Strage1 Fund has total assets of only 100 million KRW, indicating low financial transparency and raising concerns over management stability.
  • [AI Summary]B2En's change of control is negative for existing shareholders due to massive dilution from discounted capital increase and the emergence of a low-credibility new shareholder. Near-term stock price downside risk is high, and the lack of specific plans for fund use and management direction warrants investor caution.

KOSDAQ Filing Information


  • [Correction of Description] Execution of Stock Transfer Agreement Involving Change of Largest Shareholder
  • Company: B2En (307870)
  • Submission: B2En Co., Ltd.
  • Under KRX KOSDAQ Market Division

  • Shares: 74,299,285
  • Price: 1,106 KRW
  • Market Cap: 82.2 B KRW